Rein Therapeutics's total assets for Q4 2025 were $24.16M, a decrease of -8.10% from the previous quarter. RNTX total liabilities were $7.24M for the fiscal quarter, a -50.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.